NCT02366936

Brief Summary

The purpose of this study is to determine the effectiveness of the Tortle Midliner positioning system in prevention and/or treatment of dolichocephaly, which can develop in preterm infants during the hospital stay. Specific Aim: Determine if the use of the Tortle Midliner is a more effective prevention and treatment strategy for dolichocephaly than current standard of care intervention in the Duke Intensive Care Nursery (ICN).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 12, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 19, 2015

Completed
3 months until next milestone

Study Start

First participant enrolled

June 1, 2015

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
11 months until next milestone

Results Posted

Study results publicly available

April 18, 2017

Completed
Last Updated

April 15, 2024

Status Verified

March 1, 2017

Enrollment Period

1 year

First QC Date

February 12, 2015

Results QC Date

March 7, 2017

Last Update Submit

April 11, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Cranial Index (CI)

    CI was determined by calculating the ratio of the biparietal diameter (BiPD) over the occipitofrontal diameter (OFD). The BiPD is defined as the widest transverse diameter of the head. BiPD was measured from the most prominent lateral point on each side of the skull in the area of parietal and temporal bones. The OFD is defined as the diameter of the head from the most prominent midline point of the frontal bone (glabella) to the occipital protuberance. While various reported ranges exist for cranial molding norms, dolichocephaly was defined as a CI of \<76%. The normative CI range is 76-85% for prone and supine sleeping infants. CI = BPD/OFD x 100

    34 weeks gestational age

  • Number of Infants That Developed Dolichocephaly by the End of the Study

    dolichocephaly for this study is considered a cranial Index \<76% at 34 weeks post menstrual age (PMA)

    34 weeks gestational age

Study Arms (1)

Use of Tortle midliner

EXPERIMENTAL

This study will be an interventional, longitudinal study of 30 preterm infants using the Tortle Midliner.

Device: Tortle Midliner

Interventions

The Tortle Midliner is a breathable, knit beanie with two support rolls to help position the infant's head in midline while supine. It can also be worn sidelying or prone. The design includes Velcro adjustments and tabs for nasal cannula and feeding tubes. It is compatible with some ventilation devices, nasal CPAP, X-ray, and bilirubin shades. The beanie is designed to prevent dolichocephaly and provide passive stretch to cervical rotators if head preference has developed. It comes in three sizes and can fit preemies weighing 500 to 2500 g.

Use of Tortle midliner

Eligibility Criteria

Age23 Weeks - 30 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Birth weight of \<1500 g
  • Gestational age of ≤ 30 weeks
  • \<2 weeks chronological age
  • ≤30 weeks gestation at time of parent consent
  • Receiving continuous positive airway pressure (CPAP), nasal cannula or room air
  • Signed the informed consent from the legal caregiver

You may not qualify if:

  • Determined to be too medically unstable by their attending physician
  • Diagnosed with a genetic/chromosomal abnormality, congenital neuromuscular disorder, craniofacial abnormalities, congenital hydrocephalus, post-hemorrhagic hydrocephalus, or other diagnoses determined by the PI that impacts generalizability of results

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Medical Center

Durham, North Carolina, 27710, United States

Location

Limitations and Caveats

Study used the original design of the Tortle Midliner (TM). TM's new design adjustments (multiple velcro attachments, material to prevent slippage inside the cap, and doesn't cover head) may result in different outcomes based on our study protocol.

Results Point of Contact

Title
Dr. William Malcolm
Organization
Duke University Health System

Study Officials

  • William Malcolm, MD

    Duke University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 12, 2015

First Posted

February 19, 2015

Study Start

June 1, 2015

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

April 15, 2024

Results First Posted

April 18, 2017

Record last verified: 2017-03

Locations